Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 17,554 | 16,437 | 20,920 | 19,826 | 29,230 |
| Cost of Goods | 3,622 | 3,266 | 4,292 | 3,120 | 3,512 |
| Gross Profit | 13,932 | 13,171 | 16,628 | 16,706 | 25,718 |
| Operating Expenses | 19,005 | 21,604 | 92,341 | 30,921 | 29,015 |
| Operating Income | -4,451 | -8,167 | -75,421 | -14,095 | -2,785 |
| Interest Expense | 3,106 | 3,062 | 3,045 | 3,000 | 2,980 |
| Other Income | 733 | -2,163 | 74 | 633 | 1,985 |
| Pre-tax Income | -6,824 | -13,392 | -78,392 | -16,462 | -3,780 |
| Income Tax | 1,781 | -374 | -14,533 | -691 | -342 |
| Net Income Continuous | -8,605 | -13,018 | -63,859 | -15,771 | -3,438 |
| Net Income | $-8,605 | $-13,018 | $-63,859 | $-15,771 | $-3,438 |
| EPS Basic Total Ops | -0.23 | -0.35 | -1.71 | -0.43 | -0.09 |
| EPS Basic Continuous Ops | -0.23 | -0.35 | -1.72 | -0.43 | -0.09 |
| EPS Diluted Total Ops | -0.23 | -0.35 | -1.71 | -0.43 | -0.09 |
| EPS Diluted Continuous Ops | -0.23 | -0.35 | -1.72 | -0.43 | -0.09 |
| EBITDA(a) | $-3,756 | $-7,798 | $-73,682 | $-11,084 | $215 |